Literature DB >> 20039803

Piglet models of acute or chronic Clostridium difficile illness.

Jennifer Steele1, Hanping Feng, Nicola Parry, Saul Tzipori.   

Abstract

We examined the piglet model of Clostridium difficile illness (CDI) in humans, because swine are naturally susceptible to C. difficile. The piglet is a reproducible model of acute or chronic CDI with characteristic pseudomembranous colitis. Germ-free piglets were consistently and extensively colonized after oral challenge with the human strain 027/BI/NAP1, establishing an infectious dose-age relationship. This allowed a demarcation between acute fatal and chronic models. The clinical manifestations of disease inclusive of gastrointestinal and systemic symptoms and characteristic mucosal lesions of the large bowel (including pseudomembranous colitis) are described. Additionally, we demonstrate the presence of toxins in feces, body fluids, and serum and a significant elevation in interleukin 8 levels in animals with severe disease. We conclude that piglets infected with C. difficile mimic many of the key characteristics observed in humans with CDI and are suitable animals in which to investigate the role played by virulence attributes, drug efficacy, and vaccine candidates.

Entities:  

Mesh:

Year:  2010        PMID: 20039803      PMCID: PMC2804769          DOI: 10.1086/649799

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Clostridium difficile and acute respiratory distress syndrome.

Authors:  Sindhu S Jacob; Justin C Sebastian; Debra Hiorns; Sony Jacob; Prashant K Mukerjee
Journal:  Heart Lung       Date:  2004 Jul-Aug       Impact factor: 2.210

2.  Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay.

Authors:  S Johnson; S A Kent; K J O'Leary; M M Merrigan; S P Sambol; L R Peterson; D N Gerding
Journal:  Ann Intern Med       Date:  2001-09-18       Impact factor: 25.391

3.  Pseudomembranous colitis: report of a severe case with unusual clinical signs in a young nurse.

Authors:  A Boaz; M Dan; I Charuzi; O Landau; Y Aloni; S Kyzer
Journal:  Dis Colon Rectum       Date:  2000-02       Impact factor: 4.585

4.  The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection.

Authors:  S Tzipori; F Gunzer; M S Donnenberg; L de Montigny; J B Kaper; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  A rare and unsuspected complication of Clostridium difficile infection.

Authors:  Nissar Shaikh; Marie-Anne Kettern; Yolande Hanssens; Sittana S Elshafie; André Louon
Journal:  Intensive Care Med       Date:  2007-11-20       Impact factor: 17.440

6.  An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins.

Authors:  Xiangyun He; Jufang Wang; Jennifer Steele; Xingmin Sun; Weijia Nie; Saul Tzipori; Hanping Feng
Journal:  J Microbiol Methods       Date:  2009-04-23       Impact factor: 2.363

7.  Is cardiorespiratory failure induced by bacterial toxins the cause of sudden infant death syndrome? Studies with an animal model (the rabbit).

Authors:  S Siarakas; E Damas; W G Murrell
Journal:  Toxicon       Date:  1995-05       Impact factor: 3.033

8.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

9.  Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

Authors:  Xiangyun He; Xingmin Sun; Jufang Wang; Xiaoning Wang; Quanshun Zhang; Saul Tzipori; Hanping Feng
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

10.  Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.

Authors:  Guilin Yang; Boping Zhou; Jufang Wang; Xiangyun He; Xingmin Sun; Weijia Nie; Saul Tzipori; Hanping Feng
Journal:  BMC Microbiol       Date:  2008-11-06       Impact factor: 3.605

View more
  43 in total

Review 1.  Clostridium difficile in the ICU: the struggle continues.

Authors:  Linda D Bobo; Erik R Dubberke; Marin Kollef
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.

Authors:  Jennifer Steele; Kevin Chen; Xingmin Sun; Yongrong Zhang; Haiying Wang; Saul Tzipori; Hanping Feng
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

3.  A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

Authors:  Zhiyong Yang; Diane Schmidt; Weilong Liu; Shan Li; Lianfa Shi; Jinliang Sheng; Kevin Chen; Hua Yu; Jacqueline M Tremblay; Xinhua Chen; Kurt H Piepenbrink; Eric J Sundberg; Ciaran P Kelly; Guang Bai; Charles B Shoemaker; Hanping Feng
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

4.  Both, toxin A and toxin B, are important in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; Nigel P Minton
Journal:  Gut Microbes       Date:  2011-07-01

5.  Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.

Authors:  Hyeun Bum Kim; Quanshun Zhang; Xingmin Sun; Gillian Beamer; Yuankai Wang; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

6.  Prevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population.

Authors:  Keri N Norman; H Morgan Scott; Roger B Harvey; Bo Norby; Michael E Hume; Kathleen Andrews
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

7.  MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.

Authors:  Jennifer Steele; Quanshun Zhang; Gillian Beamer; Michelle Butler; Terry Bowlin; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

8.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

Review 9.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

10.  A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.

Authors:  Nicola L Davies; Joanne E Compson; Brendon Mackenzie; Victoria L O'Dowd; Amanda K F Oxbrow; James T Heads; Alison Turner; Kaushik Sarkar; Sarah L Dugdale; Mark Jairaj; Louis Christodoulou; David E O Knight; Amanda S Cross; Karine J M Hervé; Kerry L Tyson; Hanna Hailu; Carl B Doyle; Mark Ellis; Marco Kriek; Matthew Cox; Matthew J T Page; Adrian R Moore; Daniel J Lightwood; David P Humphreys
Journal:  Clin Vaccine Immunol       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.